PharmaVoice

JUNE 8, 2023

Negative news is breaking down the public’s perception of the biopharma industry — but leaders around the industry have some ideas to fix it.

97

97

Pharmaceutical Commerce

JANUARY 23, 2024

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

52

52

Fierce Healthcare

JANUARY 10, 2024

It's officially a new year for the healthcare industry, as biopharma executives, investors, reporters and others make the annual trek to the Westin St. | Get the latest healthcare and health tech news from the J.P. Morgan Healthcare Conference in San Francisco.

57

57

Fierce Pharma

NOVEMBER 30, 2023

we're highlighting two weeks' worth of biopharma news related to Asia. Because of the recent Thanksgiving holiday in the U.S., AstraZeneca in-licensed a KRAS G12D inhibitor from China's Usynova. BeiGene bought global rights to a CDK2 inhibitor in a deal worth up to $1.3

81

81

STAT

DECEMBER 8, 2023

Hired someone new and exciting? Share the news with us, and we’ll share it with others.   This time around, we note that Zenas BioPharma hired Tanya Fischer as head of R&D and chief medical officer. Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send

112

112

STAT

APRIL 20, 2023

Our colleague Helen Branswell joins us to explain the latest news on Covid-19 boosters and the implications of a Marburg outbreak in Equatorial Guinea. We also break down the rest of the week’s biggest news in biopharma, including some billion-dollar deals and the retirement of perhaps the most storied executive in the business.

Vaccines 98

Vaccines 98

STAT

APRIL 13, 2023

Jeremy Levin, CEO of Ovid Therapeutics, joins us to discuss a judge’s decision to overturn the FDA approval of an abortion pill and why he believes it’s the biggest threat to the biopharma industry in 50 years. Bernie Sanders has in his sights next. Read the rest…

FDA 98

FDA 98

Pharmaceutical Technology

JUNE 28, 2023

Shares in Centogene rose by 41% following news of the collaboration with the Saudi government-backed biopharma company.

64

64

STAT

JULY 14, 2023

Hired someone new and exciting? Share the news with us, and we’ll share it with others.  That’s Previously, he worked was founder and chief scientific officer at Xeris Biopharma. Promoted a rising star? Finally solved that hard-to-fill spot?  That’s right. Send Don’t be shy.

98

98

STAT

MARCH 17, 2023

Hired someone new and exciting? Share the news with us, and we’ll share it with others.   Previously, he worked at Zenas BioPharma, where he was senior vice president, global research, and before that, he was vice president of translational research at Boston Pharmaceuticals. Promoted a rising star?

98

98

STAT

OCTOBER 28, 2022

Hired someone new and exciting? Share the news with us, and we’ll share it with others.  Previously, he worked at Connect Biopharma as vice president, discovery biology, and before that, he was at Incyte and Novartis. Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send

98

98

STAT

APRIL 9, 2024

Venture-backed biopharma companies raised $6.8 This is the largest amount raised since the first half of 2022 — and big news for an industry that has been icy for the last three years, once the attention the Covid pandemic brought to drug companies began to fade.

Vaccines 100

Vaccines 100

European Pharmaceutical Review

APRIL 2, 2024

On his appointment , Wienand, incoming CEO, Lonza shared: “I am very much looking forward to joining Lonza and leading the company into a strong future… [helping to] serve as a partner of choice for the global biopharma industry in its quest to turn breakthrough innovations into viable therapies.

82

82

European Pharmaceutical Review

APRIL 15, 2024

This news follows the organisation’s announcement of a $2 billion investment in the facility in March 2021. FUJIFILM Corporation is planning to invest $1.2 billion to expand the planned FUJIFILM Diosynth Biotechnologies manufacturing facility in Holly Springs, North Carolina, US. billion, FUJIFILM confirmed.

82

82

The Honest Apothecary

APRIL 20, 2023

A gathering of some interesting Pharma and healthcare related news from around the web for Thursday, April 20, 2023 : What Health Systems Could Learn from Starbucks “ Sara Vaezy: Companies like Starbucks and Amazon have done really well at connecting buyers and sellers.

Specialty Pharmacies 96

Specialty Pharmacies Hospitals 96

PharmaShots

MAY 25, 2023

The companies’ focus is to develop drug delivery platforms for Belgian biopharma’s gene therapy portfolio The agreement enables UCB to use ClearPoint Neuro’s proprietary technology and services in connection with the development and commercialization of UCB’s gene therapy products.

FDA 40

FDA 40

PharmaShots

MAY 10, 2023

CTI will benefit from Sobi's resources, scale & strong international presence to expand & investigate new indications & development opportunities for Vonjo Ref: PRnewswire | Image: Sobi Related News:- CTI BioPharma’s Vonjo (pacritinib) Receives the US FDA’s Accelerated Approval for the Treatment of Myelofibrosis and Thrombocytopenia (..)

FDA 64

FDA 64

Impact Pharmaceutical Services

NOVEMBER 8, 2023

November 8, 2023, Boston, MA Syner-G BioPharma Group (Syner-G), a leading provider of integrated pharmaceutical science and regulatory consulting services to pharmaceutical and biotechnology clients, announced today that it has been named a BioSpace 2024 Best Place to Work. Voting was conducted in August, 2023.

40

40

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. Other businesses such as Redhill Biopharma or Vincerx Pharma have also announced plans for large layoffs. C-suite executives including the CEO would also depart.

129

129

PharmaShots

MAY 15, 2023

The new collaboration will combine Arcus’ research expertise with Gilead’s clinical experience to advance new therapies Ref: Gilead | Image: Gilead Related News:- Ono Entered into a Collaboration and Option Agreement with Cue Biopharma for CUE-401 to Treat Autoimmune and Inflammatory Diseases PharmaShots!

40

40

STAT

APRIL 5, 2023

But if they — or any other coffee chain, we don’t discriminate — would like to reach a devoted audience of biopharma readers on the three or so days a year I guest-write this newsletter, well my email’s right at the bottom after the news.

FDA 98

FDA 98

European Pharmaceutical Review

JULY 21, 2023

The company intends to invest approximately $90 million at its site in Ljubljana, Slovenia, to establish a dedicated Sandoz Biopharma Development Center by 2026. It also adds to news of the intended expansion of the firm’s biosimilar development capabilities at its facility in Holzkirchen, Germany in May 2023.

90

90

PharmaShots

FEBRUARY 7, 2023

Initial clinical data from this combination trial is expected to be released on a rolling basis in H1’2023 In previous preclinical studies, the combination therapy demonstrated a 50% improvement (63-day median survival) over a 4-drug combination of 2 CT and 2 immunotherapies in the genetic pancreatic cancer mouse model (KPC), in which mice develop (..)

Immunization 40

Immunization FDA 40

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. Other businesses such as Redhill Biopharma or Vincerx Pharma have also announced plans for large layoffs. Ori raised over $100 million (EUR97.52

64

64

European Pharmaceutical Review

NOVEMBER 20, 2023

News: Lilly completes biopharma acquisitions … The investment “shows good innovative products can be reliably developed and produced in Germany. With the planned additional manufacturing facility in Alzey, the company will operate a total of six manufacturing sites in Europe.

84

84

PharmaShots

MAY 19, 2023

In (XTEND-Kids) paediatric study, the trial met 1EPs with no factor VIII inhibitors detected confirming the safety profile of efanesoctocog alfa Efanesoctocog alfa, a novel & investigational recombinant factor VIII therapy was approved in the US as ALTUVIIIO in 2023 Ref: PRnewswire | Image: Sobi Related News:- Sobi to Acquire CTI BioPharma for (..)

40

40

PharmaShots

FEBRUARY 16, 2023

for NPC in 2020; FTD from the US FDA for mucosal melanoma & ODD for esophageal cancer, mucosal melanoma, soft tissue sarcoma, and SCLC Ref: Globe NewsWire | Image: Coherus Related News:- Coherus Acquires Rights from Klinge Biopharma for Eylea Biosimilar Candidate

FDA 40

FDA 40

European Pharmaceutical Review

SEPTEMBER 11, 2023

This move would help to establish its Sandoz Biopharma Development Center by 2026, the company stated when the news was announced. A total of $400 million was reported to finance a new biologics manufacturing plant in Lendava, Slovenia.

74

74

Viseven

OCTOBER 3, 2023

Veeva APAC Commerical Summit is one of the most prominent events in the Asia-Pacific region where leading companies in biopharma connect, share professional expertise, network, and have fun. This year’s APAC Commercial Summit was no exception.

52

52

pharmaphorum

DECEMBER 15, 2022

Skin health-focused biopharma Almirall announced a CEO shakeup early in November, with Gianfranco Nazzi stepping down “to pursue new professional opportunities”. Bungay formerly served as CEO of Chroma Therapeutics and COO of Mereo Biopharma. Other biopharma hires. Two hires at Almirall.

Immunization 52

Immunization Vaccines 52

PharmaShots

FEBRUARY 16, 2023

Shots: The US FDA has accepted the BLA for the proposed biosimilar trastuzumab HLX02 (submitted by the company's partner Accord BioPharma) indicated for breast cancer & metastatic gastric cancer corresponding to all the approved indications of trastuzumab The submission was based on robust structural & functional analytical data using multiple (..)

FDA 40

FDA 40

pharmaphorum

JUNE 20, 2022

Speculation that Merck & Co may be preparing a $30 billion takeover bid for Seagen – bolstering its oncology ambitions – has the biopharma community aflutter. On the WSJ Merck/Seagen story, while it's great to hear news about any potential M&A or BD, there is some bad news in there.

104

104

pharmaphorum

JANUARY 9, 2023

Biopharma and healthcare group Chiesi Farmaceutici S.p.A. The news comes only months after Chiesi Group unveiled its new €85 million Biotech Centre of Excellence in Parma, Italy – where the company was founded and is based. is to acquire the 2015-established Amryt Pharma Plc. in an all-cash transaction at $14.50 on 6 th January.

FDA 98

FDA 98

Pharma Marketing Network

JUNE 17, 2021

The median pay gap increased from 11 percent to 13 percent however there is better news looking at individual countries and industry sectors. France and the U.K. reduced the pay gap to 4.8 percent and 5.1 percent respectively, while Germany’s gap remains unchanged at 7.3.

52

52

European Pharmaceutical Review

JUNE 27, 2022

“This investment will allow for new capabilities for AstraZeneca in Ireland and support our global ambition to accelerate the development and delivery of life-changing medicines for more people affected by rare diseases.”.

78

78

pharmaphorum

SEPTEMBER 7, 2021

French biopharma company Hybrigenics has made another bid to merge with Belgium’s Bone Therapeutics, a specialist in regenerative medicine that is still recovering from a setback in its lead development programme. Hybrigenics and DMS Group merged in 2019.

94

94

pharmaphorum

JUNE 9, 2021

Biopharma companies can use these insights to engage with customers and patients in novel and intelligent ways, driving innovation and connecting healthcare professionals and patients with the knowledge they need to improve health outcomes and live better lives.

Communication 72

Communication 72